Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 3

Conditions

Breast Neoplasms 2315Neoplasms 1678Prostatic Neoplasms 1178Lung Neoplasms 908Colorectal Neoplasms 873Carcinoma, Non-Small-Cell Lung 848Leukemia, Myeloid, Acute 587Pancreatic Neoplasms 568Multiple Myeloma 542Carcinoma, Hepatocellular 510Brain Neoplasms 509Neoplasm Metastasis 456Head and Neck Neoplasms 454Melanoma 410Ovarian Neoplasms 404Glioblastoma 397Precursor Cell Lymphoblastic Leukemia-Lymphoma 390Stomach Neoplasms 370Uterine Cervical Neoplasms 355Squamous Cell Carcinoma of Head and Neck 355Rectal Neoplasms 336Recurrence 332Hematologic Neoplasms 323Sarcoma 322Colonic Neoplasms 316Lymphoma 310Triple Negative Breast Neoplasms 284Urinary Bladder Neoplasms 279Glioma 277Carcinoma, Renal Cell 277

Interventions

Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Adrenocortical Adenoma × 1 year × Clear all
NCT05368090 2026-05-08

Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

Haukeland University Hospital

Phase NA Recruiting
60 enrolled
Endocrine

Cushing Syndrome, Hyperaldosteronism, Adrenocortical Adenoma

NCT07470580 2026-03-13

ADERADHTA2

University Hospital, Toulouse

Phase NA Not yet recruiting
134 enrolled
Endocrine

Hyperaldosteronism, Hypertension, Hypokalemia, Adrenocortical Adenoma

NCT07027254 2025-06-18

PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism

Seoul National University Hospital

Phase NA Recruiting
90 enrolled
Endocrine

Hyperaldosteronism, Adrenocortical Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡